Passa al contenuto
Merck
  • Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.

Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.

Journal of experimental & clinical cancer research : CR (2015-04-19)
Steven J Conrad, Mohamed El-Aswad, Esaw Kurban, David Jeng, Brian C Tripp, Charles Nutting, Robert Eversole, Charles Mackenzie, Karim Essani
ABSTRACT

Colorectal cancers are significant causes of morbidity and mortality and existing therapies often perform poorly for individuals afflicted with advanced disease. Oncolytic virotherapy is an emerging therapeutic modality with great promise for addressing this medical need. Herein we describe the in vivo testing of recombinant variants of the tanapoxvirus (TPV). Recombinant viruses were made ablated for either the 66R gene (encoding a thymidine kinase), the 2L gene (encoding a TNF-binding protein), or both. Some of the recombinants were armed to express mouse chemotactic protein 1 (mCCL2/mMCP-1), mouse granulocyte-monocyte colony stimulating factor (mGM-CSF), or bacterial flagellin (FliC). Tumors were induced in athymic nude mice by implantation of HCT 116 cells and subsequently treated by a single intratumoral injection of one of the recombinant TPVs. Histological examination showed a common neoplastic cell type and a range of immune cell infiltration, necrosis, and tumor cell organization. Significant regression was seen in tumors treated with virus TPV/Δ2L/Δ66R/fliC, and to a lesser extent the recombinants TPV/Δ2L and TPV/Δ66R. Our results suggest that oncolytic recombinants of the TPV armed with activators of the innate immune response may be effective virotherapeutic agents for colorectal cancers in humans and should be explored further to fully realize their potential.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Metanolo, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Perossido di idrogeno, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Metanolo, HPLC Plus, ≥99.9%
Sigma-Aldrich
Perossido di idrogeno, 50 wt. % in H2O, stabilized
Sigma-Aldrich
L-glutammina, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Metanolo, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Metanolo, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
L-glutammina, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Metanolo, BioReagent, ≥99.93%
Sigma-Aldrich
Metanolo, Absolute - Acetone free
Sigma-Aldrich
Metanolo, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
SAFC
L-glutammina
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 35 wt. % in H2O
USP
Metanolo, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-glutammina, BioUltra, ≥99.5% (NT)
Millipore
Perossido di idrogeno, 3%, suitable for microbiology
Sigma-Aldrich
Metanolo, ACS reagent, ≥99.8%
Supelco
Metanolo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Perossido di idrogeno, ≥30%, for trace analysis
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Perossido di idrogeno, 34.5-36.5%
Supelco
Metanolo, analytical standard
Supelco
Perossido di idrogeno, 30 % (w/w), for ultratrace analysis
Sigma-Aldrich
L-glutammina
Sigma-Aldrich
L-glutammina, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
Metanolo, NMR reference standard
Supelco
L-glutammina, Pharmaceutical Secondary Standard; Certified Reference Material